FDA Approved: DEFENCATH — Supplemental Application (CorMedix Inc.)

View source ↗

Summary

FDA approved a supplemental application for Defencath, a taurolidine and heparin catheter-lock solution from CorMedix Inc., indicating regulatory clearance rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Drugs mentioned

• DEFENCATH (taurolidine and heparin)

Snippet

SUPPL AP for DEFENCATH (TAUROLIDINE AND HEPARIN)